Comments
Loading...
Bellerophon Therapeutics (OTC:BLPH) Stock, Earnings Estimates, EPS, And Revenue
Bellerophon Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.160
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$5.6M
Analyze the earnings history of Bellerophon Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Bellerophon Therapeutics (BLPH) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2023 | 2023-11-14 | $-0.16 | $-0.44 | 63.6 % |
| Jun 2023 | 2023-08-14 | $-0.42 | $-0.40 | -5.00 % |
| Mar 2023 | 2023-05-15 | $0.27 | $-0.49 | 155.1 % |
| Dec 2022 | 2023-03-31 | $-0.53 | $-0.48 | -10.4 % |
Bellerophon Therapeutics (BLPH) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Bellerophon Therapeutics (OTCEM:BLPH) reporting earnings?
Bellerophon Therapeutics (BLPH) is scheduled to report earnings on December 3, 2024. The last reported earnings were for reported on November 14, 2023 for Q3.
What were the latest earnings per share (EPS) for Bellerophon Therapeutics (OTCEM:BLPH)?
The Actual EPS was $-0.16, which beat the estimate of $-0.44.
What were Bellerophon Therapeutics’s (OTCEM:BLPH) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.